Table II.

Correlation between MED15 expression and hepatocellular carcinoma clinicopathological features in the GSE14520 cohort.

		MED15 expression, n
Variable	Total, n	High	Low	P-value
Sex	241			0.756
Male	210	148	62
Female	31	21	10
Age (years)	241			0.768
≤50	124	88	36
>50	117	81	36
No. of tumors	241			0.455
Solitary	189	129	60
Multiple	52	40	12
Tumor size (cm)	241			0.033a
≤5	153	100	53
>5	88	69	19
BCLC staging	217			0.031a
A	152	102	50
B + C	65	53	12
TNM staging	225			0.127
I	96	60	36
II + III	129	93	36
AFP level (ng/ml)	237			0.002a
≤300	128	78	50
>300	109	87	22
Cirrhosis	241			0.225
Yes	222	158	64
No	19	11	8
Metastasis risk	241			0.001a
Low	121	73	48
High	120	96	24
Relapse	241			0.303
Yes	136	99	37
No	105	70	35

^aValue indicates a statistically significant difference. MED15, mediator complex subunit 15; AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer.